Ellen Capon (Drug Target Review)2023-12-20T14:00:33
The first multi-chamber cardioids derived from hiPSCs have enabled scientists to investigate heart development and defects.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2026-06-09T08:20:00
Contributor Steve Smith, Drug Target Review
2024-03-08T10:00:25
Sponsored by Molecular Devices
2026-03-25T15:00:00
Sponsored by Yokogawa
2023-03-28T11:38:32
Sponsored by Bio-Techne
2026-08-10T08:58:00
Author Abhishek Jha
Site powered by Webvision Cloud